Navigation Links
Dynatronics Will Request Hearing with Nasdaq Regarding Listing Status
Date:11/8/2012

SALT LAKE CITY, Nov. 8, 2012 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that on November 7, 2012, the Company received a Nasdaq Staff Determination Letter indicating that the Company has not complied with the $1.00 minimum bid rule for continued listing set forth in Listing Rule 5550(a)(2) and faces delisting from the Nasdaq Capital Market at the opening of business on November 16, 2012, unless the Company requests an appeal of the determination by the staff.

The Company will request an appeal of the delisting determination pursuant to procedures available under the Nasdaq Listing Rules.  The hearing panel is authorized to grant additional time to regain compliance, if the panel deems it appropriate. The Company's hearing request will stay the suspension of the Company's securities pending the hearing and a final determination by the panel. As part of its appeal, the Company will be required to provide the panel with a plan to regain compliance.  The Company's plan includes a commitment to effect a reverse stock split, if necessary.

"We have filed a definitive proxy statement requesting shareholder approval for a 1 for 5 reverse stock split to regain compliance," stated Kelvyn H. Cullimore, Jr., chairman and president of Dynatronics.  "With several positive developments taking place at the Company, including the recently announced introduction of our Dynatronics SolarisPlus product line and Quad7 products, we believe Dynatronics has a strong future and will be granted the time under our plan necessary to effect our reverse split in order to regain compliance with the rule."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 15, 2012; Conference Call set for 3:30 p.m. ET
2. Dynatronics Introduces New SolarisPlus Line of Therapy Products
3. Watson and Actavis Receive FTC Second Request
4. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
5. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
6. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
7. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
9. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
10. India ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
11. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 /PRNewswire/ ... and OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... a strategic hub service that expedites and streamlines patient ... spirometer, Spiro PD 2.0, and wellness management services.  ... a medical device used to measure lung function for ...
(Date:9/12/2017)... N.J. , Sept. 12, 2017  Consumer reviews on the ... Hearing as the number one company for hearing aids, ranking ... and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... The Workgroup for Electronic Data ... to create efficiencies in healthcare information exchange and a trusted advisor to the U.S. ... industry white paper, entitled Barriers to Adoption of the ERA and EFT Transactions ...
(Date:9/19/2017)... ... , ... Driving Dynamics Inc., announced today it has been selected as a ... of its mission to continually monitor the training marketplace for the best providers of ... Health and Safety Training Companies list was based on the following criteria: , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Spain’s popular ... ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. , ACPG Laboratories has been ... a trusted, well-respected brand reliant on the healing properties of plants, a proven ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ... the Davidson Fellows Scholarship on September 27 at a reception in Washington D.C. ... Engineering, Mathematics, Literature and Music. , “I am honored to be a Davidson ...
Breaking Medicine News(10 mins):